• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LRRK2基因的I2012T、G2019S和I2020T突变在特发性震颤患者中并不常见。

The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor.

作者信息

Deng Hao, Le WeiDong, Davidson Anthony L, Xie WenJie, Jankovic Joseph

机构信息

Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, TX 77030, USA.

出版信息

Neurosci Lett. 2006 Oct 23;407(2):97-100. doi: 10.1016/j.neulet.2006.08.012. Epub 2006 Aug 30.

DOI:10.1016/j.neulet.2006.08.012
PMID:16939701
Abstract

Several mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have been identified both in familial and sporadic cases of Parkinson's disease (PD). G2019S, located at a kinase (MAPKKK) domain, is the most common mutation in the LRRK2 gene in PD, Two adjacent mutations (I2012T and I2020T) were mapped to the same domain suggesting shared pathogenic mechanism of these mutations. Since phenotypes of PD overlap with essential tremor (ET), we investigated LRRK2 G2019S, I2012T, and I2020T mutations in a cohort of 272 patients with ET. No mutations were found in our ET cohort and, therefore, we conclude that LRKK2 I2012T, G2019S and I2020T variants are rare causes of Caucasian ET.

摘要

在帕金森病(PD)的家族性和散发性病例中均已发现富含亮氨酸重复激酶2基因(LRRK2)的几种突变。位于激酶(MAPKKK)结构域的G2019S是PD中LRRK2基因最常见的突变。两个相邻突变(I2012T和I2020T)被定位到同一结构域,提示这些突变具有共同的致病机制。由于PD的表型与特发性震颤(ET)重叠,我们在一组272例ET患者中研究了LRRK2 G2019S、I2012T和I2020T突变。在我们的ET队列中未发现突变,因此,我们得出结论,LRKK2 I2012T、G2019S和I2020T变异是白种人ET的罕见病因。

相似文献

1
The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor.LRRK2基因的I2012T、G2019S和I2020T突变在特发性震颤患者中并不常见。
Neurosci Lett. 2006 Oct 23;407(2):97-100. doi: 10.1016/j.neulet.2006.08.012. Epub 2006 Aug 30.
2
The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?患有帕金森病的阿什肯纳兹犹太人中LRRK2基因G2019S突变:是否存在性别效应?
Neurology. 2007 Oct 16;69(16):1595-602. doi: 10.1212/01.wnl.0000277637.33328.d8.
3
The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease.LRRK2基因的I2012T、G2019S和I2020T突变在台湾散发性帕金森病患者中较为罕见。
Parkinsonism Relat Disord. 2005 Dec;11(8):521-2. doi: 10.1016/j.parkreldis.2005.09.003. Epub 2005 Oct 26.
4
Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.在以北美为基础的家族性帕金森病样本中,除G2019S外,LRRK2基因的其他突变很少见。
Mov Disord. 2006 Dec;21(12):2257-60. doi: 10.1002/mds.21162.
5
A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.俄罗斯家族性和散发性帕金森病中常见的富含亮氨酸重复序列激酶2基因突变。
Eur J Neurol. 2007 Apr;14(4):413-7. doi: 10.1111/j.1468-1331.2007.01685.x.
6
Clinical heterogeneity of the LRRK2 G2019S mutation.LRRK2基因G2019S突变的临床异质性。
Arch Neurol. 2006 Sep;63(9):1242-6. doi: 10.1001/archneur.63.9.1242.
7
Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients.印度帕金森病患者中常见报道的LRRK2突变的缺失/罕见情况。
Neurosci Lett. 2006 Dec 1;409(2):83-8. doi: 10.1016/j.neulet.2006.04.052. Epub 2006 Oct 18.
8
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.撒丁岛帕金森病患者群体中五个LRRK2突变的基因分析:G2019S和R1441C突变在散发性帕金森病患者中的重要性
Parkinsonism Relat Disord. 2009 May;15(4):277-80. doi: 10.1016/j.parkreldis.2008.06.009. Epub 2008 Sep 20.
9
Screening for LRRK2 mutations in patients with Parkinson's disease in Russia: identification of a novel LRRK2 variant.俄罗斯帕金森病患者中LRRK2突变的筛查:一种新型LRRK2变异体的鉴定
Eur J Neurol. 2008 Jul;15(7):692-6. doi: 10.1111/j.1468-1331.2008.02149.x. Epub 2008 Apr 24.
10
LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.西班牙帕金森病患者的LRRK2突变:频率、临床特征及不完全外显率
Arch Neurol. 2006 Mar;63(3):377-82. doi: 10.1001/archneur.63.3.377.

引用本文的文献

1
The age at onset of LRRK2 p.Gly2019Ser Parkinson's disease across ancestries and countries of origin.LRRK2基因p.Gly2019Ser突变型帕金森病在不同血统和原产国的发病年龄。
medRxiv. 2025 Jun 9:2025.06.04.25327685. doi: 10.1101/2025.06.04.25327685.
2
Genomic Markers for Essential Tremor.特发性震颤的基因组标记
Pharmaceuticals (Basel). 2021 May 27;14(6):516. doi: 10.3390/ph14060516.
3
Genetic and Environmental Factors Influence the Pleomorphy of Parkinsonism.遗传和环境因素影响帕金森病的多态性。
Int J Mol Sci. 2021 Jan 21;22(3):1045. doi: 10.3390/ijms22031045.
4
Case-control analysis of LRRK2 protective variants in Essential Tremor.LRRK2 保护性变异与特发性震颤的病例对照分析。
Sci Rep. 2018 Mar 28;8(1):5346. doi: 10.1038/s41598-018-23711-w.
5
Genetic analysis of the leucine-rich repeat and lg domain containing Nogo receptor-interacting protein 1 gene in essential tremor.LRRC37A 基因中富含亮氨酸重复和 lg 结构域的 Nogo 受体相互作用蛋白 1 在特发性震颤中的遗传分析。
J Mol Neurosci. 2013 Oct;51(2):403-7. doi: 10.1007/s12031-013-0029-1. Epub 2013 Jun 12.
6
Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S.II 型激酶抑制剂对帕金森病相关 LRRK2 突变体 G2019S 表现出一种意想不到的抑制模式。
Biochemistry. 2013 Mar 12;52(10):1725-36. doi: 10.1021/bi3012077. Epub 2013 Mar 1.
7
Replication of the LINGO1 gene association with essential tremor in a North American population.LINGO1 基因与北美人群特发性震颤的复制关联。
Eur J Hum Genet. 2010 Jul;18(7):838-43. doi: 10.1038/ejhg.2010.27. Epub 2010 Apr 7.
8
Role of LINGO1 polymorphisms in Parkinson's disease.LINGO1 多态性在帕金森病中的作用。
Mov Disord. 2009 Dec 15;24(16):2404-7. doi: 10.1002/mds.22768.
9
Mutations in the Parkinson's disease genes, Leucine Rich Repeat Kinase 2 (LRRK2) and Glucocerebrosidase (GBA), are not associated with essential tremor.帕金森病基因,富亮氨酸重复激酶 2(LRRK2)和葡萄糖脑苷脂酶(GBA)的突变与特发性震颤无关。
Parkinsonism Relat Disord. 2010 Feb;16(2):132-5. doi: 10.1016/j.parkreldis.2009.05.008. Epub 2009 Jun 13.
10
DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease.多巴胺受体D3基因Ser9Gly多态性和造血细胞特异性蛋白1结合蛋白3基因Ala265Gly多态性与帕金森病无关。
Neurosci Lett. 2009 Sep 18;461(2):74-5. doi: 10.1016/j.neulet.2009.05.084. Epub 2009 Jun 12.